Rajeev M. Shah is of Black Diamond Therapeutics, Inc.. Currently has a direct ownership of 0 shares of BDTX, which is worth approximately $0. The most recent transaction as insider was on May 20, 2021, when has been sold 443 shares (Common Stock) at a price of $24.01 per share, resulting in proceeds of $10,636. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Rajeev M. Shah Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 20 2021
SELL
Other acquisition or disposition
$10,636 $24.01 p/Share
443 Reduced 100.0%
0 Common Stock
Mar 18 2021
BUY
Grant, award, or other acquisition
$10,636 $24.01 p/Share
443 Added 50.0%
443 Common Stock

Also insider at

STSA
Satsuma Pharmaceuticals, Inc. Healthcare
SLDB
Solid Biosciences Inc. Healthcare
KALA
Kala Pharmaceuticals, Inc. Healthcare
RMS

Rajeev M. Shah

South San Francisco, CA

Track Institutional and Insider Activities on BDTX

Follow Black Diamond Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BDTX shares.

Notify only if

Insider Trading

Get notified when an Black Diamond Therapeutics, Inc. insider buys or sells BDTX shares.

Notify only if

News

Receive news related to Black Diamond Therapeutics, Inc.

Track Activities on BDTX